Benjamin Cheek, MD
Obstetrics & Gynecology · Columbus, GANPI 1093712598
Payments from drug & device makers
Across 124 payments — averaging $28.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Sales And Service, LLC$645
- AbbVie$570
- Astellas Pharma US Inc$508
- Fujirebio Diagnostics, Incorporated$350
- Pfizer$214
- Coopersurgical, Inc.$183
- plus $1K from 24 others
What the payments were for
- Consulting fees$60017%
- Food & beverage$2,80079%
- Education$1003%
- Gifts$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hologic Sales And Service, LLC | 14 | $645 |
| AbbVie(2 entities) | 27 | $570 |
| Astellas Pharma US Inc | 22 | $508 |
| Fujirebio Diagnostics, Incorporated | 1 | $350 |
| Pfizer | 14 | $214 |
| Coopersurgical, Inc. | 6 | $183 |
| Boston Scientific | 3 | $175 |
| Myriad Women's Health, Inc. | 1 | $127 |
| Gen-probe, Inc. | 1 | $107 |
| Sumitomo Pharma America, Inc. | 5 | $98 |
| Caldera Medical, Inc | 2 | $84 |
| Therapeuticsmd, Inc. | 3 | $60 |
| Myovant Sciences Inc. | 4 | $48 |
| Shield Therapeutics Inc | 2 | $48 |
| Mylan Pharmaceuticals Inc. | 2 | $30 |
| Evofem Biosciences, Inc. | 2 | $28 |
| BD | 1 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Biogen | 1 | $25 |
| Organon | 1 | $24 |
| Roche Diagnostics Corporation | 1 | $20 |
| Bayer | 1 | $19 |
| Amgen | 1 | $18 |
| Covidien LP | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $15 |
| Exeltis, USA Inc. | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
| Baxter Healthcare | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYOSURE TISSUE REMOVAL DEVICE$250
- myRisk$127
- Myosure$124
- NovaSure$124
- Aptima HPV$107
- co testing$107
- Aptima M genitalium$107
- Vaginitis$107
How this compares
$3,536 in reported general payments places this provider in the 80th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 462 | $26,375 |
| PremarinEstrogens, Conjugated | 20 | $7,416 |
| OsphenaOspemifene | 19 | $7,362 |
| YuvafemEstradiol | 15 | $3,556 |
| Estradiol (Twice Weekly)Estradiol | 26 | $2,711 |
| Clobetasol Propionate | 41 | $2,451 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 19 | $2,423 |
| Estradiol (Once Weekly)Estradiol | 20 | $2,333 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 16 | $1,832 |
| DottiEstradiol | 11 | $1,693 |
| ProgesteroneProgesterone, Micronized | 35 | $886 |
| Duloxetine Hcl | 25 | $641 |
| Fluconazole | 69 | $617 |
| Metronidazole | 11 | $482 |
| Medroxyprogesterone Acetate | 20 | $478 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $214 | $7,41620 claims |
| Duchesnay USA IncorporatedOsphena | $15 | $7,36219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Other obstetrics & gynecology in Columbus
- Serena TidwellColumbus$617K
- Timothy VillegasColumbus$300K
- James DorchakColumbus$33K
- Gretchen MitchellCumming$4.5M
- Stephen BlankAtlanta$3.5M
- Eric BrownAtlanta$1.7M
- Melissa KottkeAtlanta$1.7M
- Allan DinnersteinFort Stewart$1.5M
- David MontaldiMarietta$1.1M
- Winifred SoufiAtlanta$889K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.